Nuclear Antigen anticorps
Aperçu rapide pour Nuclear Antigen anticorps (ABIN6297660)
Antigène
Voir toutes Nuclear Antigen (IPO-38) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- Mouse anti-Human/Mouse/Rat IPO-38 Antibody (Proliferation Marker) [Sodium Azide Free]
-
Specificité
- Nuclear
-
Purification
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
-
Immunogène
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
-
-
-
-
Indications d'application
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 0.5-1 μg/mL
Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1)
Prediluted format: incubate for 30 min at RT (2) -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- Nuclear Antigen (IPO-38)
-
Autre désignation
- IPO38
-
Sujet
-
Target Description: Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO38 antigen is present in the nuclei of proliferating cells such as Hodgkin s disease and non-Hodgkin s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO38 may be a useful marker of cell proliferation during monitoring of tumor progression.
Antigène
-